Concord Drugs Ltd.
Concord Drugs
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹1.12 Cr.
No Subsidiaries Data available
Concord Drugs is a public limited company established in the year 1995. The company is one among selected few pharmaceutical companies in India with dedicated state of art WHO-GMP certified facility. The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide its customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. The company has manufacturing license issued by the Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad.
Concord Drugs operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products. Concord Drugs Limited has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.
Business area of the company:
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery.
Products
Concord Drugs offers products of international standards through innovations with foresight of its responsibility towards the Society at large:
